Francis John Ballard

Francis John Ballard's AcademicInfluence.com Rankings

Biology

#7379

World Rank

#10293

Historical Rank

Biochemistry

#1017

World Rank

#1130

Historical Rank

biology Degrees

Download Badge

Biology

Francis John Ballard's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is Francis John Ballard Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Francis John Ballard's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Phosphoenolpyruvate carboxykinase and pyruvate carboxylase in developing rat liver. (1967) (345)
Production and utilization of acetate in mammals. (1974) (319)
The relative significance of acetate and glucose as precursors for lipid synthesis in liver and adipose tissue from ruminants. (1967) (266)
Lysosomes : their role in protein breakdown (1987) (246)
Gluconeogenesis and lipogenesis in tissue from ruminant and nonruminant animals. (1969) (197)
Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. (1992) (183)
Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. (1988) (180)
Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. (1967) (177)
Changes in lipid synthesis in rat liver during development. (1967) (175)
New opportunities from the isolation and utilization of whey proteins. (1996) (175)
Glycogen metabolism in embryonic chick and neonatal rat liver. (1963) (170)
Inhibition of protein degradation in isolated rat hepatocytes. (1977) (162)
Selective control of the degradation of normal and aberrant proteins in Reuber H35 hepatoma cells. (1976) (159)
Purification of phosphoenolpyruvate carboxykinase from the cytosol fraction of rat liver and the immunochemical demonstration of differences between this enzyme and the mitochondrial phosphoenolpyruvate carboxykinase. (1969) (155)
Changes in the Growth-Promoting Activity of Human Milk during Lactation (1984) (143)
Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1. (1989) (142)
A possible physiological role for glyceroneogenesis in rat adipose tissue. (1970) (140)
3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use. (1983) (133)
The citrate cleavage pathway and lipogenesis in rat adipose tissue: replenishment of oxaloacetate. (1967) (126)
Citrate, pyruvate, and lactate contaminants of commercial serum albumin. (1968) (122)
The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding. (1988) (121)
IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. (1991) (118)
Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. (1986) (115)
Purification and properties of rat liver fructokinase. (1967) (110)
GLUCOSE UTILIZATION IN MAMMALIAN LIVER. (1965) (109)
CARBOHYDRATE METABOLISM IN LIVER FROM FOETAL AND NEONATAL SHEEP. (1965) (108)
Chicken insulin-like growth factor-I: amino acid sequence, radioimmunoassay, and plasma levels between strains and during growth. (1990) (103)
Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum. (1986) (101)
Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. (1992) (100)
Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. (1992) (95)
The regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat kidney cortex. The role of acid-base balance and glucocorticoids. (1975) (95)
Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. (1990) (93)
Reduced rates of proteolysis in transformed cells (1977) (93)
Rapid loss of translatable messenger RNA of phosphoenolpyruvate carboxykinase during glucose repression in liver. (1974) (92)
Synthesis and degradation of phosphoenolpyruvate carboxylase in rat liver and adipose tissue. Changes during a starvation-re-feeding cycle. (1973) (92)
Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding. (1987) (90)
Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver. (1969) (87)
Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats. (1991) (85)
Effects of carbohydrate availability on lipogenesis in sheep. (1972) (79)
The effect of ethanol and acetaldehyde on DNA synthesis in growing cells and on fetal development in the rat. (1981) (79)
Report on the nomenclature of the IGF binding proteins. (1992) (79)
Extraction from cheese whey by cation-exchange chromatography of factors that stimulate the growth of mammalian cells. (1995) (76)
Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in the rat. (1975) (75)
Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion. (1979) (74)
Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. (1993) (74)
Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. (1991) (74)
Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins. (1992) (73)
Influence of nutrition on hepatic IGF-I mRNA levels and plasma concentrations of IGF-I and IGF-II in meat-type chickens. (1996) (72)
Purification and properties of galactokinase from pig liver. (1966) (71)
Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. (1993) (70)
The appearance of gluconeogenesis at birth in sheep. Activation of the pathway associated with blood oxygenation. (1977) (68)
Classification of the insulin-like growth factor binding proteins into three distinct categories according to their binding specificities. (1988) (68)
Protein degradation in hepatocyte monolayers. Effects of glucagon, adenosine 3':5'-cyclic monophosphate and insulin. (1980) (67)
Sheep insulin-like growth factors I and II: sequences, activities and assays. (1989) (67)
Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion. (1979) (66)
Inhibition of protein breakdown in cultured cells is a consistent response to growth factors (1980) (66)
Effects of cyclic adenosine monophosphate, dexamethasone and insulin on phosphoenolpyruvate carboxykinase synthesis in Reuber H-35 hepatoma cells. (1975) (65)
Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. (1998) (65)
The initial synthesis of proteins during development. Phosphoenolpyruvate carboxylase in rat liver at birth. (1972) (63)
Growth factor concentrations and growth-promoting activity in human milk following premature birth. (1985) (62)
A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide. (1989) (62)
Rapid and reversible inhibition of junctional communication by tumor promoters in a mouse cell line. (1983) (62)
Transforming growth factor beta in bovine milk: concentration, stability and molecular mass forms. (1996) (61)
Metabolic Changes in Liver Associated with Spontaneous Ketosis and Starvation in Cows (1968) (60)
Effects of anabolic agents on protein breakdown in L6 myoblasts. (1983) (59)
Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor (IGF)-I and des(1-3)IGF-I. (1991) (59)
Ketohexokinase, isoenzymes of glucokinase and glycogen synthesis from hexoses in neonatal rat liver. (1964) (57)
Utilization of oxidizable substrates by the sheep hind limb: effects of starvation and exercise. (1976) (55)
Identification of vitronectin as a novel insulin-like growth factor-II binding protein. (1999) (54)
Insulin inhibition of protein degradation in cell monolayers (1980) (54)
Immunochemical studies with soluble and mitochondrial pyruvate carboxylase activities from rat tissues. (1970) (53)
Regulation of protein accumulation in cultured cells. (1982) (53)
Increased degradation rates of protein synthesized in hepatoma cells in the presence of amino acid analogues. (1975) (53)
The development of gluconeogenesis in rat liver: experiments in vivo. (1969) (52)
DEVELOPMENTAL CHANGES IN THE PLASMA PROTEIN PATTERN OF THE RAT. (1963) (52)
Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. (1996) (52)
The development of gluconeogenesis in rat liver. Controlling factors in the newborn. (1971) (52)
Treatment with IGF-I peptides improves function of the remnant gut following small bowel resection in rats. (1994) (50)
Developmental changes in growth hormone, insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in plasma of young growing pigs. (1991) (49)
Metabolism of glucose, fructose and lactate in vivo in chronically cannulated foetuses and in suckling lambs. (1977) (47)
Purification, partial sequences and properties of chicken insulin-like growth factors. (1988) (46)
Alterations in translatable messenger RNA coding for phosphoenolpyruvate carboxykinase (GTP) in rat liver cytosol during deinduction. (1978) (45)
Kinetic studies with liver galactokinase. (1966) (44)
Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively. (1988) (44)
Increased rates of myofibrillar protein breakdown in muscle‐wasting diseases (1981) (44)
Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II. (1989) (44)
Enzyme inactivation via disulphide-thiol exchange as catalysed by a rat liver membrane protein. (1980) (43)
Ontogeny and secretory patterns of plasma insulin-like growth factor-I concentrations in meat-type chickens. (1990) (43)
Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. (1993) (42)
Evolution of insulin-like growth factor binding proteins. (1993) (42)
Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells (1995) (42)
Insulin-like growth factor-I (IGF-I) and IGF-binding proteins both decline in the rat during late pregnancy. (1990) (41)
Evolution of insulin-like growth factor-I (IGF-I) action: in vitro characterization of vertebrate IGF-I proteins. (1998) (41)
The regulation of phosphoenolpyruvate carboxykinase in fetal rat liver. (1973) (39)
The relationship between the insulin content and inhibitory effects of bovine colostrum on protein breakdown in cultured cells (1982) (39)
Intracellular protein degradation. (1977) (39)
Infulence of hormones and medium composition on the degradation of phosphoenolpyruvate carboxykinase (GTP) and total protein in Reuber H35 cells. (1976) (39)
Kinetic studies with cytosol and mitochondrial phosphoenolpyruvate carboxykinases. (1970) (38)
Stimulation by glucocorticoids of protein degradation in hepatocyte monolayers. (1981) (38)
Multiple biotin-containing proteins in 3T3-L1 cells. (1986) (36)
Transport of IGF-I across epithelial cell monolayers. (1999) (36)
Platelet-derived growth factor, insulin-like growth factors, fibroblast growth factors and transforming growth factor beta do not account for the cell growth activity present in bovine milk. (1997) (36)
Is dietary epidermal growth factor absorbed by premature human infants? (1989) (36)
An insulin-like growth factor-binding protein purified from medium conditioned by a human lung fibroblast cell line (He[39]L) has a novel N-terminal sequence. (1990) (36)
The effect of concentration on glucose phosphorylation and incorporation into glycogen in the livers of foetal and adult rats and sheep. (1964) (36)
The role of the adrenals in the regulation of phosphoenolpyruvate carboxykinase of rat adipose tissue. (1969) (35)
Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. (1995) (35)
Nutritional and Hormonal Effects on Intracellular Protein Catabolism. (2009) (34)
Plasma clearance of chicken and human insulin-like growth factor-I and their association with circulating binding proteins in chickens. (1990) (34)
Regulation of phosphoenolpyruvate carboxykinase (GTP) in adipose tissue in vivo by glucocorticoids and insulin. (1976) (33)
Continuous 14 day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. (1995) (33)
Administration of insulin-like growth factor-I, but not growth hormone, increases maternal weight gain in late pregnancy without affecting fetal or placental growth. (1991) (33)
Probing the disulfide folding pathway of insulin-like growth factor-I. (1999) (33)
Distribution and degradation of biotin-containing carboxylases in human cell lines. (1985) (32)
Metabolic and endocrine interrelationships in normal and diabetic sheep. (1974) (32)
Enhanced potency of truncated insulin-like growth factor-I (des(1-3)IGF-I) relative to IGF-I in lit/lit mice. (1990) (32)
Amino acid uptake and output by the sheep hind limb. (1976) (32)
Adenine nucleotides and the adenylate kinase equilibrium in livers of foetal and newborn rats. (1970) (31)
Pathway of carbon flow during fatty acid synthesis from lactate and pyruvate in rat adipose tissue. (1971) (31)
Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1. (1986) (31)
The development of gluconeogenesis in rat liver. Effects of glucagon and ether. (1970) (31)
Effects of weak bases on the degradation of endogenous and exogenous proteins by rat yolk sacs. (1980) (30)
Phosphopyruvate carboxylase induction by L-tryptophan. Effects on synthesis and degradation of the enzyme. (1973) (30)
Most of the circulating insulin-like growth factors-I and -II are present in the 150 kDa complex during human pregnancy. (1991) (30)
Regulation of gluconeogenesis during exposure of young rats to hypoxic conditions. (1971) (30)
Identification of fibroblast growth factors in bovine cheese whey (1995) (30)
Phosphoenolpyruvate synthesis and release by mitochondria from guinea pig liver. (1969) (30)
Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis. (2002) (30)
Degradation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in vivo and in vitro. (1974) (30)
Regulation of phosphoenolpyruvate metabolism in mitochondria from guinea pig liver. (1970) (29)
Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs. (1993) (29)
The metabolic fate of the products of citrate cleavage. Adenosine triphosphate-citrate lyase and nicotinamide-adenine dinucleotide phosphate-linked malate dehydrogenase in foetal and adult liver from ruminants and non-ruminants. (1968) (29)
Energy metabolism in free-living, ‘large-eating’ and ‘small-eating’ women: studies using 2H218O (1994) (29)
Evolution of insulin-like growth factor (IGF) function: production and characterization of recombinant hagfish IGF. (1997) (28)
The relative stability of liver cytosol enzymes incubated in vitro. (1974) (28)
Is orally-derived epidermal growth factor beneficial following premature birth or intestinal resection? (1986) (28)
Chemical and biological characterization of chicken insulin-like growth factor-II. (1990) (28)
In vivo actions of IGF analogues with poor affinities for IGFBPs: metabolic and growth effects in pigs of different ages and GH responsiveness. (1995) (28)
Production and characterization of recombinant chicken insulin-like growth factor-I from Escherichia coli. (1992) (27)
Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. (1994) (27)
Muscle protein degradation in premature human infants. (1979) (26)
Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. (1995) (26)
Measurement of adipose-tissue metabolites in vivo. (1969) (25)
Characterization of insulin-like growth factor-binding proteins in rat serum, lymph, cerebrospinal and amniotic fluids, and in media conditioned by liver, bone and muscle cells. (1990) (24)
Appearance of Fructose-1,6-Diphosphatase in Post-Natal Rat Liver (1962) (24)
Regulation of the breakdown rates of biotin-containing proteins in Swiss 3T3-L1 cells. (1988) (24)
Differences in energy metabolism between normal weight ‘large-eating’ and ‘small-eating’ women (1992) (24)
Liver growth in early postpartum rat. (1962) (23)
Effects of microbial proteinase inhibitors on the degradation of endogenous and internalized proteins by rat yolk sacs. (1981) (23)
The effect of insulin and glucocorticoids on the synthesis and degradation of phosphoenolpyruvate carboxykinase (GTP) in rat adipose tissue cultured in vitro. (1976) (23)
A rapid method for the analysis of N tau-methylhistidine in human urine. (1981) (23)
Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects. (1993) (23)
Changes in protein synthesis and breakdown rates and responsiveness to growth factors with ageing in human lung fibroblasts (1985) (21)
Differential changes in the milk concentrations of epidermal growth factor and insulin-like growth factor-I during lactation in the tammar wallaby, Macropus eugenii. (1995) (20)
IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. (1997) (20)
IGF-I and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass. (1991) (20)
Characterization and cloning of a bovine insulin-like growth factor-binding protein. (1990) (20)
Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection. (1996) (19)
Inhibition of pyruvate carboxylase degradation and total protein breakdown by lysosomotropic agents in 3T3-L1 cells. (1983) (19)
Inactivation of phosphoenolypyruvate carboxykinase (GTP) by liver extracts. (1976) (19)
Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. (1999) (19)
Modification of animal growth with growth hormone and insulin-like growth factors (1993) (19)
Factors controlling the concentration of mitochondrial oxaloacetate in liver during spontaneous bovine ketosis. (1968) (18)
Conjoint IGF-I and Insulin Infusion Shows Diverse Interactive Effects in Diabetic Rats (1996) (17)
Phosphoenolpyruvate carboxykinase. II. Hormonal controls. (1973) (17)
Insulin-like growth factor-binding proteins in tissue fluids from the lamb. (1991) (17)
C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells. (1987) (17)
The progression of Duchenne muscular dystrophy (1981) (17)
Growth hormone but not insulin‐like growth factor‐I improves wound strength in pigs (1997) (16)
Characterization of serum-derived and recombinant rat IGF-I and their use for measuring true concentrations of IGF-I in rat plasma. (1996) (16)
Synthesis of insulin-like growth factor I using N-methyl pyrrolidinone as the coupling solvent and trifluoromethane sulphonic acid cleavage from the resin. (2009) (15)
Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction. (1991) (15)
Creatinine excretion as an index of myofibrillar protein mass in dystrophic mice. (1981) (15)
Distribution and partial purification of a liver membrane protein capable of inactivating cytosol enzymes. (1980) (15)
THE SIGNIFICANCE OF MITOCHONDRIAL PHOSPHOENOLPYRUVATE FORMATION IN THE REGULATION OF GLUCONEOGENESIS IN GUINEA PIG LIVER (1972) (15)
Measurements of myofibrillar protein breakdown in newborn human infants. (1982) (14)
Inhibition of protein breakdown by epidermal growth factor in IMR90 human fibroblasts and other mammalian cell lines. (1983) (14)
Effects of insulin-like growth factors on protein metabolism: why are some molecular variants more potent? (1989) (14)
Factors in ruminant colostrum that influence cell growth and murine IgE antibody responses (1992) (13)
Effects of insulin-like growth factor-I peptides in rats with acute renal failure. (1994) (13)
Regulation of protein breakdown by epidermal growth factor in A431 cells. (1985) (13)
Synthesis of phosphoenolpyruvate carboxykinase (guanosine triphosphate) by isolated liver polyribosomes. (1974) (13)
Role of mitochondria in metabolism of pyruvate and lactate by rat adipose tissue. (1971) (13)
Properties of synthetic-gene recombinant human epidermal growth factor: comparison with the natural growth factor from human urine and milk. (1986) (12)
No major differences in energy metabolism between matched and unmatched groups of ‘large-eating’ and ‘small-eating’ men (1993) (12)
Effects of fasting and refeeding on the concentrations of glycolytic intermediates and the regulation of lipogenesis in rat adipose tissue in vivo. (1972) (12)
Pyruvate dehydrogenase activity in rat liver during development. (1974) (11)
Rapid changes in plasma concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IGF-binding proteins during anaesthesia in young sheep. (1994) (11)
CHAPTER 3 – Hormonal Control of Protein Degradation in Liver and Isolated Cells (1980) (11)
Properties of phosphoenolpyruvate carboxykinase (guanosine triphosphate) synthesized in hepatoma cells in the presence of amino acid analogues. (1975) (11)
Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin‐like growth factor (IGF)‐I (1996) (11)
Carbohydrate Metabolism and the Regulation of Blood Glucose (1978) (10)
Plasma half-lives of native and modified insulin-like growth factor-I in lambs. (1988) (10)
Regulation of intracellular protein degradation by insulin and growth factors. (1981) (10)
Expression, purification and characterization of secreted recombinant human insulin-like growth factor-I (IGF-I) and the potent variant des(1-3) IGF-I in Chinese hamster ovary cells. (1991) (10)
Electrophoretic and chromatographic separation of phosphoenolpyruvate carboxykinases. (1971) (9)
In vitro characterization and in vivo clearance of recombinant barramundi (Lates calcarifer) IGF-I (1999) (9)
Physiological role and regulation of glyceroneogenesis in rat adipose tissue. (1972) (8)
Growth hormone-induced changes in myofibrillar protein breakdown in hypopituitary children. (1983) (8)
Effects of amino acid analogues on protein synthesis and degradation in isolated cells (1978) (8)
Differences in substrate metabolism between self-perceived 'large-eating' and 'small-eating' women. (1995) (8)
Insulin-like growth factor I and its variant, des(1-3)IGF-I, improve nitrogen balance and food utilization in rats with renal failure. (1992) (7)
Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins. (1994) (7)
Proceedings: Gluconeogenesis in fetal and neonatal lambs. (1974) (7)
Glyceride-Glycerol Synthesis from Pyruvate (2003) (7)
The epidermal growth factor-mediated inhibition of growth in A431 cells is accompanied by an atypical stimulation of protein breakdown. (1984) (7)
The development of gluconeogenic function in rat liver. (1970) (7)
Degradation of extracellular protein by the isolated perfused rat liver. A biochemical and autoradiographic study. (1979) (6)
Regulation of protein breakdown in hepatocyte monolayers. (1979) (6)
Accelerated breakdown of reticulocyte protein formed under conditions of amino acid depletion. (1978) (6)
The role of pyruvate carboxylase and phosphopyruvate carboxylase (P-enolpyruvate carboxykinase) in adipose tissue. (1970) (6)
[7] Galactokinase from pig liver (1975) (6)
Production and characterization of recombinant chicken insulin-like growth factor-II from Escherichia coli. (1995) (6)
Protein synthesis and breakdown rates associated with the insulin resistance of fibroblasts from patients with leprechaunism. (1985) (6)
Degradation of native and modified forms of fructose-bisphosphate aldolase microinjected into HeLa cells. (1988) (4)
Pathways of fructose conversion into glucose in foetal rat liver. (1965) (4)
ALLOPURINOL INEFFECTIVE IN DUCHENNE MUSCULAR DYSTROPHY (1981) (4)
Inactivation of Cytosol Enzymes by a Liver Membrane Fraction (1981) (4)
The concentrations of metabolites of glucose in rat adipose tissue cells in vitro. (1970) (4)
Degradation of horseradish peroxidase after microinjection into mammalian cells. (1988) (4)
Attempts to relate enzyme inactivation to degradation in vivo. (1977) (3)
Proteolysis of N-ethylmaleimide-modified aldolase loaded into erythrocyte ghosts: prevention by inhibitors of calpain. (1989) (3)
Effects of inhibitors on aldolase breakdown after its microinjection into HeLa cells. (1989) (3)
Partial isolation and translation in vitro of messenger ribonucleic acid for phosphoenolpyruvate carboxykinase (guanosine triphosphate). (1976) (3)
Coordinate regulation of protein synthesis and breakdown in cultured cells. (1985) (3)
Cell culture as a tool for identifying nutritional disease therapies. (1994) (3)
Effects of insulin on protein synthesis in muscles from normal and dystrophic mice (1983) (2)
Sequential urinary Nτ‐methylhistidine to creatinine ratios in premature infants (1986) (2)
Degradation of Enzymes (1980) (2)
The relationship between insulin binding and the inhibition of protein degradation in normal and transformed cells. (1980) (2)
Increased Degradation Rates of Canavanine-Containing Proteins in Hepatoma Cells (1977) (2)
Regulation of protein metabolism and DNA synthesis by fibroblast growth factor in BHK-21 cells. (1988) (2)
Changes in Protein Synthesis and Degradation Involved in Enzyme Accumulation in Differentiating Liver (1973) (2)
Degradation of microinjected glycolytic enzymes in L6 myoblasts. (1986) (1)
Galactokinase from pig liver. (1975) (1)
The Role of Pyruvate Carboxylase and P-enolpyruvate Carboxykinase in Rat Adipose Tissue (1971) (1)
The progression of Duchenne muscular dystrophy (1981) (1)
Structure‐Function Studies on Bombesin and Related Peptides: Biological Effects on Swiss 3T3 Cells and Two‐Dimensional 1H‐NMR Analysis (1988) (1)
Inactivation of cytosol enzymes by a liver membrane protein. (1979) (1)
Muscle protein breakdown in premature human infants. (1989) (1)
The synthesis of lipid from acetate by bovine teat canal epithelium in vitro. A preliminary report. (1968) (1)
MUSCLE PROTEIN BREAKDOWN IN HUMAN CATABOLIC STATES (1981) (1)
Ribosomal patterns from fetal and newborn rat liver (1969) (1)
A Potent Growth Factor Supplement For Cell Culture Purified From Whey (1997) (1)
Procede de traitement de troubles intestinaux (1991) (0)
Method for the treatment of intestinal diseases (1991) (0)
Development of Unique Growth Factors for Serum-Free Cell Culture using Fusion Partner Technology (1997) (0)
Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. (1999) (0)
Production of a Novel Recombinant TGFα-Like Fusion Protein for Use in Serum-Free Media (1999) (0)
IGF analogues: their development and use (1996) (0)
Structure/function studies on bombesin and related peptides: Their biological effects on swiss 3T3 cells and two-dimensional 1H NMR analyses (1987) (0)
Book Review:The Insulin-Like Growth Factors: Structure and Biological Functions. Paul N. Schofield (1993) (0)
Letters to the editor (1982) (0)
Milk growth factors: concentrations in human milk and effects of premature birth (1985) (0)
Modified growth factor of milk (1995) (0)
Insulin-like growth factor ( IGF )-ll binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-11 (2005) (0)
A rapid, automated method for the determination of 3-methylhistidine in human urine (1982) (0)
Insulin-like growth factor-I and insulin are synergistic for reversal of catabolism (1996) (0)
Intellectual property licensing : a case study of dairy wastes : Foods of the Future (1996) (0)
Restricted nutrition and protein turnover. (1978) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Francis John Ballard?

Francis John Ballard is affiliated with the following schools: